Lessons learned from cardiovascular outcome clinical trials with dipeptidyl peptidase 4 (DPP-4) inhibitors
Crossref DOI link: https://doi.org/10.1007/s12020-015-0811-7
Published Online: 2015-11-26
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fiorentino, Teresa Vanessa
Sesti, Giorgio
Text and Data Mining valid from 2015-11-26